InvestorsHub Logo
Followers 40
Posts 1638
Boards Moderated 0
Alias Born 07/12/2014

Re: Drugdoctor post# 117581

Wednesday, 03/29/2017 1:05:11 PM

Wednesday, March 29, 2017 1:05:11 PM

Post# of 119915
LoL....even with the anemic turnover revenue 0f say $30M annually right now we should be trading at market cap half that or about .38.

Now what if the following happens:

1. New Seanie International CEO named.
2. UK/Irish/Malta license for Seanie approved this summer.
3. New major updates to Optima platform prior to our own license approval.

The key is - and always has been - can they end the toxic dilution? IF they are able to keep Apollo locked out and retire notes without dilution and secondly, IF they are able to free up funds for Shane to push turnover revenue to $100 million annually, then what is price? And IMO with the right amount of funds Shane could have turnover revs that high in matter of months.

Now add the possibility of a private placement investor or investment banker investor deal that gives Seanie a loan with good terms in exchange for percentage ownership. What happens to price then?

We should be in the $1-3.00 range IMO but it ALL depends on IF they can end dilution and toxic debt financing.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.